How Effective Does a New Drug for Amytrophic Lateral Sclerosis Need to Be? The Patient Perspective.
Submission to Taylor & Francis Online: Peer Reviewed Journals Andrew Darke PhD and Cali Orsulak BSc Pharm A recent paper by Boddy et al (2025)1 advanced the argument that new drugs for ALS should only be considered to be effective if they demonstrate a separation from placebo in total ALSFRS-R score of 3.8 points, over […]